Premium
GE HealthCare Technologies Inc (GEHC)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong ... GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. Show more
New joint research program combines UCSF’s advanced clinical and research teams with GE HealthCare’s technical and engineering expertise to develop solutions that directly impact patient care...
The multi-year collaboration enables expanded access to quality diagnostic care for patients in California and provides Sutter physicians and clinicians with access to technology advances and...
GE HealthCare (Nasdaq: GEHC) will announce its fourth quarter and full year 2024 financial results before the market opens on Thursday, February 13, 2025. The GE HealthCare management team will...
More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE...
Determined to reach net zero emissions by 2050, GE HealthCare’s portfolio features environmentally conscious product design, energy efficiency, and technology circularity while continuing to...
CleaRecon DL* is designed to improve cone-beam computed tomography (CBCT) image quality by removing streaks and help clinicians improve their confidence in image interpretation when analyzing...
GE HealthCare to acquire 50% stake from Sumitomo Chemical to assume full ownership of NMP, subject to regulatory approvals As part of GE HealthCare, NMP, already a leading radiopharmaceutical...
New 3D imaging capabilities of Sonic DL are designed to enable up to 86%i faster scans and enhanced resolution for brain, spine, orthopedic and body imaging. Combination of Sonic DL and AIR...
Booth (#7330) will showcase new innovations that address the most pressing challenges in healthcare, spanning the care journey across devices, disease states and digital tools New product...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1854 | -0.217146872804 | 85.38 | 86.34 | 82.86 | 3156384 | 84.50078136 | CS |
| 4 | 7.6246 | 9.82931545701 | 77.57 | 87.26 | 76.8912 | 3195016 | 81.69229469 | CS |
| 12 | -4.0654 | -4.5545597132 | 89.26 | 90.16 | 76.8912 | 3364618 | 83.05449069 | CS |
| 26 | 2.6046 | 3.15365056302 | 82.59 | 94.55 | 76.8912 | 3027301 | 85.04590519 | CS |
| 52 | 10.9546 | 14.7556573276 | 74.24 | 94.55 | 71.31 | 3075547 | 84.02892928 | CS |
| 156 | 31.0646 | 57.3888786255 | 54.13 | 94.55 | 53.813 | 3007954 | 78.40539084 | CS |
| 260 | 31.0646 | 57.3888786255 | 54.13 | 94.55 | 53.813 | 3007954 | 78.40539084 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
